Phase 1 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with heterozygous familial hypercholesterolemia (an inherited condition that causes high cholesterol) or with early-onset coronary artery disease (heart disease that developed at a younger age than typical)
Who may not be able to join:
- People who have homozygous familial hypercholesterolemia (a more severe inherited form of high cholesterol involving two copies of the faulty gene, rather than one)
- People who currently have, or have had in the past, a long-term liver condition or disease
- People who are currently being treated with a type of cholesterol-lowering medicine called a PCSK9 inhibitor, or who have been treated with one within a certain period of time before the trial (confirm exact timeframe with trial site)
- People whose blood test results show certain abnormal values as defined by the trial's medical guidelines (confirm specifics with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 317-615-4559
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Incidence of treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.